Pmv Pharmaceuticals Inc (PMVP) — Financial Flexibility Index
Pmv Pharmaceuticals Inc (PMVP) has a Financial Flexibility Index of -1.54x as of September 2025. Free cash flow of $-19.82 Million (operating CF $-19.82 Million minus capex $1.00K) represents -2% of total liabilities ($12.85 Million). Also explore how fast is Pmv Pharmaceuticals Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pmv Pharmaceuticals Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Pmv Pharmaceuticals Inc across 8 annual periods. Check asset allocation strategy of Pmv Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Pmv Pharmaceuticals Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Pmv Pharmaceuticals Inc. For the full company profile including market capitalisation, see Pmv Pharmaceuticals Inc (PMVP) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.21x | $-73.55 Million | $-73.58 Million | $11.85 Million | ▼ -86.4% |
| 2024 | -3.33x | $-50.63 Million | $-51.28 Million | $15.21 Million | ▼ -61.1% |
| 2023 | -2.07x | $-54.70 Million | $-55.66 Million | $26.46 Million | ▲ +10.0% |
| 2022 | -2.30x | $-55.78 Million | $-63.76 Million | $24.28 Million | ▼ -16.9% |
| 2021 | -1.97x | $-45.22 Million | $-46.57 Million | $23.01 Million | ▲ +61.3% |
| 2020 | -5.08x | $-32.59 Million | $-32.74 Million | $6.41 Million | ▼ -3917.9% |
| 2019 | -0.13x | $-21.96 Million | $-22.07 Million | $173.51 Million | ▲ +5.8% |
| 2018 | -0.13x | $-14.73 Million | $-15.18 Million | $109.60 Million | — |